CorMedix Inc.  

(Public, NYSEMKT:CRMD)   Watch this stock  
Find more results for CRMD
1.88
Jul 11 - Close
NYSEMKT real-time data - Disclaimer
Currency in USD
Range     -
52 week 0.66 - 3.20
Open     -
Vol / Avg. 0.00/73,930.00
Mkt cap 41.35M
P/E     -
Div/yield     -
EPS -1.38
Shares 21.99M
Beta -0.80
Inst. own 16%

Key stats and ratios

Q1 (Mar '14) 2013
Net profit margin -136994.20% -456655.00%
Operating margin -24053.69% -318753.00%
EBITD margin - -245512.00%
Return on average assets -1053.28% -443.24%
Return on average equity - -
Employees 2 -
CDP Score - -

Address

Suite 303, 745 Route 202-206
BRIDGEWATER, NJ 08807
United States - Map
+1-908-5179500 (Phone)
+1-908-4294307 (Fax)

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

CorMedix Inc. (CorMedix) is a biopharmaceutical company that focuses on in-licensing, developing and commercializing therapeutic products for the treatment of cardiac and renal dysfunction, also know as Cardiorenal disease. The Company has licensed all of the products in its Cardiorenal pipeline. The Company has several product candidates in clinical development, including its product candidates, CRMX003 (CorMedix Neutrolin), a liquid designed to prevent central venous catheter infection and clotting initially in dialysis catheters, and CRMX001 (the Company�s formulation of the drug deferiprone), which targets the prevention of contrast-induced nephropathy in patients.

Officers and directors

Randy Milby Chief Executive Officer, Director
Age: 59
Bio & Compensation  - Reuters
Antony E. Pfaffle M.D. Vice Chairman of the Board
Age: 49
Bio & Compensation  - Reuters
Steven W. Lefkowitz Interim Chief Financial Officer, Director
Age: 57
Bio & Compensation  - Reuters
Michael W. George Director
Age: 63
Bio & Compensation  - Reuters
Matthew P. Duffy Independent Director
Age: 50
Bio & Compensation  - Reuters
Taunia S. Markvicka Pharm.D. Independent Director
Age: 45
Bio & Compensation  - Reuters
Cora M. Tellez Independent Director
Age: 63
Bio & Compensation  - Reuters